Physician profile
Joseph Seta
NPI 1376167817
$18,296.95
in general payments reported to CMS, 2019-2025
11 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,666 · 2022: $1,652 · 2023: $2,151 · 2024: $1,281 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Food and Beverage: $2,503 · Travel and Lodging: $1,141 · Education: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Food and Beverage | $2,503.38 |
| Travel and Lodging | $1,141.45 |
| Education | $334.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,000.00 | 2025 | |
| Medical Device Business Services, INC. | $3,399.70 | 2021-2023 | Actis |
| Pinnacle, INC | $2,424.19 | 2021-2024 | |
| Stryker Corporation | $886.92 | 2023-2025 | Blueprint Patient Specific Instrumentation, Ortholoc 3di, Gamma |
| Depuy Synthes Sales INC. | $605.03 | 2021-2025 | Na, Dynacord, Inhance |
| Smith+Nephew, INC. | $257.30 | 2025 | Real Intelligence, Pico 7, Renasys Touch |
| Illuminoss Medical, INC. | $168.02 | 2024 | |
| Zimmer Biomet Holdings, INC. | $158.37 | 2021 | |
| Heron Therapeutics, INC. | $145.57 | 2024 | Zynrelef |
| Aroa Biosurgery Incorporated | $138.45 | 2024 | |
| Endo Pharmaceuticals INC. | $113.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Seta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.